What 12 Analyst Ratings Have To Say About Insulet
Portfolio Pulse from Benzinga Insights
Over the last quarter, Insulet (NASDAQ:PODD) has received 12 analyst ratings, with 2 being bullish, 4 somewhat bullish, and 6 indifferent. The company's average 12-month price target is $275.42, a 17.15% decrease from the previous average of $332.42.
September 06, 2023 | 2:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Insulet has received mixed analyst ratings over the last quarter, with the average 12-month price target showing a decrease. This could potentially impact the stock's performance.
Analyst ratings are a significant factor in influencing investor sentiment and stock performance. The mixed ratings and decreased price target for Insulet suggest a potential negative impact on the stock's short-term performance.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100